2018
DOI: 10.1016/j.dsi.2018.06.002
|View full text |Cite
|
Sign up to set email alerts
|

Caveolin-1 expression in hyperproliferative skin disorders: A potential predictive marker of disease severity and progression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
16
0

Year Published

2019
2019
2020
2020

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(17 citation statements)
references
References 22 publications
1
16
0
Order By: Relevance
“…Dysregulation of Cav1 expression in the human skin is associated with hyperproliferative diseases such as melanoma and non-melanoma cancers but also psoriasis (Carè et al, 2011; Gheida et al, 2018; Kruglikov and Scherer, 2019). In melanoma, Cav1 function remains very controversial, since it is recognized as a tumor suppressor and an oncogene (Felicetti et al, 2009; Trimmer et al, 2010).…”
Section: Discussionmentioning
confidence: 99%
“…Dysregulation of Cav1 expression in the human skin is associated with hyperproliferative diseases such as melanoma and non-melanoma cancers but also psoriasis (Carè et al, 2011; Gheida et al, 2018; Kruglikov and Scherer, 2019). In melanoma, Cav1 function remains very controversial, since it is recognized as a tumor suppressor and an oncogene (Felicetti et al, 2009; Trimmer et al, 2010).…”
Section: Discussionmentioning
confidence: 99%
“…One study compared immunohistochemical expression of Cav1 in patients with cutaneous SCC with normal control skin specimens and observed a statistically significant downregulation of Cav1 expression in SCCs compared to the control group, in both intensity and pattern of expression. [157] Furthermore, poorly differentiated SCCs showed significantly reduced Cav1 expression compared to moderately and well-differentiated SCCs, suggesting that Cav1 downregulation not only plays a role in the promotion of SCC tumorigenesis, but also in its progression. The study went on to explore the potential role of Cav1 in the pathogenesis on non-melanoma skin cancers (NMSCs) and ultimately found that levels of Cav1 expression could be used as predictive biomarkers for patients at risk of cancer progression.…”
Section: Cav1 In Cutaneous Squamous Cell Carcinomas (Sccs)mentioning
confidence: 93%
“…The study went on to explore the potential role of Cav1 in the pathogenesis on non-melanoma skin cancers (NMSCs) and ultimately found that levels of Cav1 expression could be used as predictive biomarkers for patients at risk of cancer progression. [157] Murine models of cutaneous SCC demonstrate similar relationship between Cav1 and tumor development, where mice overexpressing Cav1 exhibit decreased in vitro cell proliferation, as well as decreased in vivo tumor incidence, volume and weight. [158] Conversely, Cav1-null mice exhibit increased cell and tumor growth, in addition to increased invasive ability and incidence of spontaneous lymph node metastasis, which is likely due to hyperactivation of the MAPK pathway in the Cav1-null mice, [158] thus introducing…”
Section: Cav1 In Cutaneous Squamous Cell Carcinomas (Sccs)mentioning
confidence: 94%
See 2 more Smart Citations